Cargando…
Tumor-specific delivery of therapeutic siRNAs by anti-EGFR immunonanoparticles
BACKGROUND: Efficient target-specific siRNA delivery has always been a primary concern in the field of siRNA clinical application. PURPOSE: In this study, four different types of anti-epidermal growth factor receptor (EGFR) antibody-conjugated immunonanoparticles were prepared and tested for cancer...
Autores principales: | Kim, Jung Seok, Kim, Min Woo, Kang, Seong Jae, Jeong, Hwa Yeon, Park, Sang Il, Lee, Yeon Kyung, Kim, Hong Sung, Kim, Keun Sik, Park, Yong Serk |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6118344/ https://www.ncbi.nlm.nih.gov/pubmed/30214190 http://dx.doi.org/10.2147/IJN.S161932 |
Ejemplares similares
-
Anti-EGF Receptor Aptamer-Guided Co-Delivery of Anti-Cancer siRNAs and Quantum Dots for Theranostics of Triple-Negative Breast Cancer
por: Kim, Min Woo, et al.
Publicado: (2019) -
Galactosylated Liposomes for Targeted Co-Delivery of Doxorubicin/Vimentin siRNA to Hepatocellular Carcinoma
por: Oh, Hea Ry, et al.
Publicado: (2016) -
Gemcitabine-loaded PLGA-PEG immunonanoparticles for targeted chemotherapy of pancreatic cancer
por: Aggarwal, Sahil, et al.
Publicado: (2013) -
Polyethylenimine-Conjugated Hydroxyethyl Cellulose for Doxorubicin/Bcl-2 siRNA Co-Delivery Systems
por: Park, Jiwon, et al.
Publicado: (2023) -
Sendai F/HN Viroplexes for Efficient Transfection of Leukemic T Cells
por: Kim, Jung Seok, et al.
Publicado: (2013)